206 related articles for article (PubMed ID: 17968950)
1. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythematosus-like syndrome.
Han B; Moore PA; Wu J; Luo H
Arthritis Rheum; 2007 Nov; 56(11):3748-58. PubMed ID: 17968950
[TBL] [Abstract][Full Text] [Related]
2. DcR3 as a diagnostic parameter and risk factor for systemic lupus erythematosus.
Han B; Bojalil R; Amezcua-Guerra LM; Springall R; Valderrama-Carvajal H; Wu J; Luo H
Int Immunol; 2008 Aug; 20(8):1067-75. PubMed ID: 18562337
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus.
Lee CS; Hu CY; Tsai HF; Wu CS; Hsieh SL; Liu LC; Hsu PN
Clin Exp Immunol; 2008 Mar; 151(3):383-90. PubMed ID: 18190609
[TBL] [Abstract][Full Text] [Related]
4. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice.
Ka SM; Sytwu HK; Chang DM; Hsieh SL; Tsai PY; Chen A
J Am Soc Nephrol; 2007 Sep; 18(9):2473-85. PubMed ID: 17687076
[TBL] [Abstract][Full Text] [Related]
5. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
Han B; Wu J
J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
[TBL] [Abstract][Full Text] [Related]
6. DcR3 mutations in patients with juvenile-onset systemic lupus erythematosus lead to enhanced lymphocyte proliferation.
Chokdeemeeboon C; Ammarinthnukrowh P; Tongkobpetch S; Srichomtong C; Deekajorndech T; Rianthavorn P; Kingwattanakul P; Avihingsanon Y; Wright HL; Akkahat P; Hoven VP; Mekboonsonglarp W; Edwards SW; Hirankarn N; Suphapeetiporn K; Shotelersuk V
J Rheumatol; 2013 Aug; 40(8):1316-26. PubMed ID: 23729807
[TBL] [Abstract][Full Text] [Related]
7. Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function.
Wang YL; Chou FC; Sung HH; Fan PL; Hsueh CW; Lin WC; Chen SJ; Lin WW; Sytwu HK
Mol Immunol; 2010 Oct; 47(16):2552-62. PubMed ID: 20801512
[TBL] [Abstract][Full Text] [Related]
8. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
[TBL] [Abstract][Full Text] [Related]
10. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
[TBL] [Abstract][Full Text] [Related]
11. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
[TBL] [Abstract][Full Text] [Related]
12. Functional characterisation of decoy receptor 3 in Crohn's disease.
Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
[TBL] [Abstract][Full Text] [Related]
13. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
[TBL] [Abstract][Full Text] [Related]
14. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
[TBL] [Abstract][Full Text] [Related]
15. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
16. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.
Stohl W; Xu D; Kim KS; Koss MN; Jorgensen TN; Deocharan B; Metzger TE; Bixler SA; Hong YS; Ambrose CM; Mackay F; Morel L; Putterman C; Kotzin BL; Kalled SL
Arthritis Rheum; 2005 Jul; 52(7):2080-91. PubMed ID: 15986357
[TBL] [Abstract][Full Text] [Related]
17. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
18. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages.
Tai SK; Chang HC; Lan KL; Lee CT; Yang CY; Chen NJ; Chou TY; Tarng DC; Hsieh SL
J Immunol; 2012 Mar; 188(5):2464-71. PubMed ID: 22287720
[TBL] [Abstract][Full Text] [Related]
20. Characterization of novel antigens recognized by serum autoantibodies from anti-CD1 TCR-transgenic lupus mice.
Hueber W; Zeng D; Sharpe O; Robinson WH; Strober S; Utz PJ
Eur J Immunol; 2004 Jun; 34(6):1654-62. PubMed ID: 15162435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
